Cargando…
Treatment of Essential Hypertension does not Normalize Capillary Rarefaction
OBJECTIVES: To determine if capillary rarefaction persists when hypertension is treated with angiotensin converting enzyme inhibitor, thiazidic diuretic and/or beta-blocker, and to identify which microcirculatory alterations (structural and functional) persist after anti-hypertensive treatment. METH...
Autores principales: | de Araújo Penna, Guilherme Loures, de Freitas Garbero, Rodrigo, Neves, Mario Fritsch, Oigman, Wille, Bottino, Daniel Alexandre, Bouskela, Eliete |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664718/ https://www.ncbi.nlm.nih.gov/pubmed/18925320 http://dx.doi.org/10.1590/S1807-59322008000500008 |
Ejemplares similares
-
Target Organ Damage in Hypertension
por: Neves, Mario Fritsch, et al.
Publicado: (2012) -
Capillary rarefaction: an early marker of microvascular disease in young hemodialysis patients
por: Edwards-Richards, Alcia, et al.
Publicado: (2014) -
Capillary rarefaction from the kidney point of view
por: Afsar, Baris, et al.
Publicado: (2018) -
Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
por: Bosch, Agnes J., et al.
Publicado: (2017) -
Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension
por: Frost, Shaun, et al.
Publicado: (2021)